IBD Screen of the Day: Analysts boost profit margins on these tops

Using the IBD’s Rising Profit Estimates screen, investors can find stocks with the greatest potential for growth. These are just some of the names on the list that are currently at the top of their respective IBD groups.


Shares of Clean Harbors (CLH) is trading near 110.77 buy points after breaking a cup with a handle last week. The waste management services company is surpassing its peers and ranks first in IBD’s Pollution Control Industry Group.

Impressive revenue growth is the main reason for this outperformance. The company has a strong three-year revenue growth rate of 39%. This growth rate is expected to accelerate further, with EPS growth for the first quarter estimated at 69%.

Clean Harbors shares showed more strength in a report last month Waste management (WM) is looking at potential acquisitions of the company. The interest comes when waste management is thinking of an expansion into more environmentally friendly disposal solutions.

Top REIT Rexford Industrial earnings estimates

For investors who want to dive into real estate, there is a strong choice Rexford Industrial Realty (REXR). Industry REIT – with a portfolio of properties in Southern California – has shown strong growth. Funds from operations (FFO) increased by 12% in the first quarter of 2021, followed by gains of 22%, 30% and 32% by the end of the year.

Rexford will report results on April 20. FFO growth is expected to slow to 9% for Q1 and 15% for 2022 vs. one year earlier numbers.

IBD’s finance property currently tops the REIT group, with Rexford topping 175 other stocks. The stock currently has a smooth cup base with 81.78 buy points.

Synopsys chip raises profit outlook on demand

Semiconductor design and verification stock Synopsis (SNPS) is showing strong growth with a three year EPS growth rate of 26%. Strong demand has seen the Synopsys company’s recent earnings call extend the 2022 guideline further.

EPS of $ 6.84 last year is expected to increase to 22 7.91 and $ 9.20 in 2022 and 2023, respectively. Strong growth has led Synopsys to lead IBD’s consumer software group. It boasts a strong IBD composite rating of 97.

Tuesday, Synopsys and Juniper Networks (JNPR) has announced a partnership to form a new silicon photonics company aimed at taking advantage of the rapidly expanding photonics market.

Synopsys is creating a cup pattern with 377.70 buy points per stock marketsmith.

You may also like:

Get Free IBD Newsletter: Market Preparation | Tech Report | How to invest

What is Can Slim? If you want to find winning stocks, know this better

IBD Live: Learn and analyze growth stocks with professionals

Marketsmith’s tools can help the individual investor

Related Posts

Leave a Reply

Your email address will not be published.